1.	Photodynamic Therapy to Treat Actinic Damage in Patients With Squamous Cell Carcinoma (SCC) of the Lip Phase: Phase IV Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: PDT for Lip, NCT00868088
2.	Study of NPC-07 for Fluorescence-guided Resection of Malignant Gliomas Phase: Phase III Type: Biomarker/Laboratory analysis, Diagnostic Status: Completed Age: 18 to 70 Sponsor: Pharmaceutical / Industry Protocol IDs: NPC-07-1, NCT01167322
3.	Treatment of Oral Premalignant Lesions With 5-ALA PDT Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 to 80 Sponsor: Other Protocol IDs: 51439, NCT00571974
4.	Photodynamic Therapy in Treating Patients With Skin Cancer Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: DS 92-42, RPCI-DS-92-42, NCI-V97-1191, NCT00002963
5.	Photodynamic Therapy in Treating Patients With Skin Cancer Phase: Phase II Type: Treatment Status: Completed Age: Not specified Sponsor: NCI, Other Protocol IDs: CDR0000065494, RPCI-DS-96-55, NCI-G97-1224, NCT00002975
6.	Photodynamic Therapy in Treating Patients With Lymphoma or Chronic Lymphocytic Leukemia Phase: Phase II Type: Supportive care, Treatment Status: Completed Age: Not specified Sponsor: NCI, Other Protocol IDs: DS 97-32, RPCI-DS-9732, NCT00054171
7.	Imaging Procedure Using ALA in Finding Residual Tumor in Grade IV Malignant Astrocytoma Phase: Phase II Type: Diagnostic Status: Temporarily closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CASE1305, P30CA043703, NCT00752323
8.	A Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain Phase: Phase II Type: Diagnostic Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: 5-ALA-01, NCT01403311
9.	Levulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK) Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CP0106, NCT01458587
10.	Short-incubation Levulan Photodynamic Therapy Versus Vehicle for Face/Scalp Actinic Keratosis (AK) Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CP0105, NCT01475955
11.	Study of Aminolevulinic Acid to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain Phase: Phase I Type: Diagnostic, Treatment Status: Completed Age: Any age Sponsor: Other Protocol IDs: 4079, NCT00671710
12.	Fluorescence Guided Resection of Brain Tumors Phase: Phase I Type: Diagnostic Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: DMS 0711, R01 NS052274-01A2, NCT00870779
13.	Topical Aminolevulinic Acid in Patients With Nonmelanoma Skin Cancer Phase: No phase specified Type: Diagnostic, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CASE-9Z07-CC417, P30CA043703, P01CA084203, NCT00663910
14.	Photodynamic Therapy With Levulan® +/- Topical Retinoid Pre-Treatment In The Treatment Of Actinic Keratoses Phase: No phase specified Type: Prevention, Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: INV-0901, NCT01053000